Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Nov 14 2022 | Bridging the Gap: Advancing Health Equity in Heart Failure Patient News Heart Failure Awareness 365 Patient Resource Read More Nov 7 2022 | FARXIGA improved symptom burden and health-related quality of life in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial Industry News Industry Read More Nov 7 2022 | Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease Industry News In The News Industry Read More Nov 6 2022 | HFSA President's Update: November 2022 HFSA News President's Updates Read More Nov 2 2022 | Meet the New Co-Hosts of the Heart Failure Beat Podcast HFSA News Podcasts Provider Education Read More Pagination First page « First Previous page ‹ Previous … Page 54 Page 55 Page 56 Page 57 Current page 58 Page 59 Page 60 Page 61 Page 62 … Next page Next › Last page Last »
Nov 14 2022 | Bridging the Gap: Advancing Health Equity in Heart Failure Patient News Heart Failure Awareness 365 Patient Resource Read More
Nov 7 2022 | FARXIGA improved symptom burden and health-related quality of life in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial Industry News Industry Read More
Nov 7 2022 | Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease Industry News In The News Industry Read More
Nov 2 2022 | Meet the New Co-Hosts of the Heart Failure Beat Podcast HFSA News Podcasts Provider Education Read More
